Nanotechnology Now

Our NanoNews Digest Sponsors
Heifer International



Home > Press > Grapheal raises EUR1.9 million to advance development of embedded biosensing technology and application in digital COVID testing and wound monitoring: Includes seed financing from Novalis Biotech and private investors, support from Bpifrance as well as non-dilutive grants

Abstract:
Grapheal, a developer of graphene-based embedded biosensors for on-site diagnostics and remote patient monitoring, announced today that it has raised a total of EUR1.9 million in equity and non-dilutive sources, including seed financing from Novalis Biotech’s Acceleration Fund, several innovation grants, and Bpifrance convertible notes and loans.

Grapheal raises EUR1.9 million to advance development of embedded biosensing technology and application in digital COVID testing and wound monitoring: Includes seed financing from Novalis Biotech and private investors, support from Bpifrance as well as non-dilutive grants

Grenoble, France | Posted on February 10th, 2021

The funds will be used to advance the industrialization of Grapheal’s flexible graphene-based biosensor technology. This sensing technology combines novel electronic nanomaterials, embedded wireless electronics, software data analysis, and medical cloud IoT technologies. The first two applications of the technology will be a new generation digital COVID-19 test (TestNPass) for rapid screening in high-traffic areas, such as airports, and a wound care digital assistant (WoundLAB) to improve the monitoring of hard-to-heal wounds. The funds will also be used to validate the two devices in the field and complete clinical studies, respectively.

“Grapheal merges digital bioelectronic sensing technologies with connectivity into embedded systems for on-site diagnostics and remote patient monitoring, so is a perfect fit to the Novalis portfolio” said Wim Van Criekinge, co-founder of Novalis Biotech, who has also been appointed to the Grapheal Board of Directors. “There is enormous potential for applications of their digital technology in the medical field, but the rapid COVID-19 saliva test could be the game-changing test the world needs to safely return to normal, particularly at airports, concert halls, and stadiums. Their technology is delivering a tamper-proof sanitary pass that is confidential and compliant with stringent data privacy regulations, such as European GDPR. This is definitely a critical asset for their differentiation with competing products.”

TestNPass is Grapheal’s diagnostic test based on saliva sampling that can be used to rapidly screen for the COVID-19 infection. Within 5 minutes, the digital test detects the presence of the virus without the requirement of dedicated reading equipment other than a smartphone or a standard NFC-connected device. When the SARS-CoV-2 virus binds to antibodies contained in TestNPass, a specific electrical signal is detected. This signal can be captured electronically on the device, which speeds up the diagnosis and allows the result's secure digital transfer.

WoundLAB is a flexible and transparent graphene-based biosensor patch that continuously records and stores wound biochemical parameters. A smartphone app is then used to communicate this data to a telemedicine cloud for data aggregation and further analysis. This allows caregivers to monitor wound healing in their patients remotely, with prompt alerts if any infections or medical complications arise.

“We are very thankful to everyone that participated in our funding, from the seed capital provided by Novalis Biotech, each grant approval, and the Grenoble and La French Tech teams at Bpifrance for their continuous support,” said Dr. Vincent Bouchiat, CEO of Grapheal. “The medical applications of graphene are only just beginning to be explored, and we are leading those endeavors. With this funding in place, we believe our first product could be on the market before the end of 2021.”

####

About Grapheal
Grapheal develops wearable and disposable sensors based on graphene that enables continuous monitoring and diagnosis. These flexible biosensors empower caregivers with an improved and individualized assessment tool for precision medicine. The company is among the first in Europe to focus on healthcare applications of graphene. Grapheal is a spin-off from the Neel Institute at the French National Centre for Scientific Research (CNRS). CNRS, together with Grenoble University (UGA) licensed key patents to Grapheal, which was incubated and supported by Grenoble’s technology transfer office SATT Linksium. Since its creation in 2019, Grapheal received numerous innovation awards, including the French i-Lab and i-Nov prizes, EDF Pulse prize, EU-funded EIT Health Headstart award, and was integrated into several acceleration entrepreneurship programs worldwide (HEC Challenge+, Creative Destruction Lab, MassChallenge, and NETVA). Grapheal is also an associate member of the Graphene Flagship, a EUR 1 billion, 10-year collaborative program supported by the European Union. Grapheal is based on the former works in nanoelectronics and material science performed by the CNRS team lead by Dr. Vincent Bouchiat, combined with the engineering expertise in digital connectivity of Behnaz Djoharian. Both are co-founders of the company. For more information, please visit www.grapheal.com.

About Novalis Biotech
Novalis Biotech (Ghent, Belgium) is an early stage venture capital investor in technologies that revolutionize healthcare. The company’s core competence lies in digitalization in the life sciences with a focus on bioinformatics, genomics and diagnostics. Novalis strongly believes in applying innovative enabling technology to advance the prevention, diagnosis, or treatment of a disease. Novalis Biotech Acceleration (Fund II) announced the first closing in November 2020.
For more information, please visit www.noval.is.

For more information, please click here

Contacts:
Grapheal Novalis Halsin Partners (media)
Dr. Vincent Bouchiat Jan Van den Berghe Mike Sinclair
+33 456387074 +44 20 7318 2955

Copyright © Grapheal

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

Solvent study solves solar cell durability puzzle: Rice-led project could make perovskite cells ready for prime time September 23rd, 2022

Heat-resistant nanophotonic material could help turn heat into electricity: The key to beating the heat is degrading the materials in advance September 23rd, 2022

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

“Twisty” photons could turbocharge next-gen quantum communication: Team’s on-chip technology uses orbital angular momentum to encode more information into a single photon September 23rd, 2022

Graphene/ Graphite

Buckyballs on gold are less exotic than graphene July 22nd, 2022

A novel graphene based NiSe2 nanocrystalline array for efficient hydrogen evolution reaction July 15th, 2022

OCSiAl expands its graphene nanotube production capacities to Europe June 17th, 2022

Bumps could smooth quantum investigations: Rice University models show unique properties of 2D materials stressed by contoured substrates June 10th, 2022

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

180 Degree Capital Corp. Reports +6.7% Growth in Q4 2020, $9.28 Net Asset Value per Share as of December 31, 2020, and Developments from Q1 2021 Including Expected Investment in a Planned SPAC Sponsor February 22nd, 2021

180 Degree Capital Corp. to Report Fourth Quarter 2020 Financial Results on Monday, February 22, 2021 and to Host a Conference Call on Tuesday, February 23, 2021 February 19th, 2021

Possible Futures

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

“Twisty” photons could turbocharge next-gen quantum communication: Team’s on-chip technology uses orbital angular momentum to encode more information into a single photon September 23rd, 2022

Wrapping of nanosize copper cubes can help convert carbon dioxide into other chemicals September 23rd, 2022

Upgrading your computer to quantum September 23rd, 2022

Investments/IPO's/Splits

Daikin Industries becomes OCSiAl shareholder July 27th, 2021

180 Degree Capital Corp. Reports +14.2% Growth in Q1 2021, $10.60 Net Asset Value Per Share as of March 31, 2021, and Developments From Q2 2021 May 11th, 2021

INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021

180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021

Nanomedicine

Georgia State researchers discover novel way to treat IBD with lipid nanoparticles August 26th, 2022

Engineers fabricate a chip-free, wireless electronic “skin”: The device senses and wirelessly transmits signals related to pulse, sweat, and ultraviolet exposure, without bulky chips or batteries August 19th, 2022

Immune system: First image of antigen-bound T-cell receptor at atomic resolution: Antigen binding does not trigger any structural changes in T-cell receptors – Signal transduction probably occurs after receptor enrichment August 19th, 2022

How different cancer cells respond to drug-delivering nanoparticles: The findings of a large-scale screen could help researchers design nanoparticles that target specific types of cancer July 22nd, 2022

Announcements

Heat-resistant nanophotonic material could help turn heat into electricity: The key to beating the heat is degrading the materials in advance September 23rd, 2022

Chicago Quantum Exchange welcomes six new partners highlighting quantum technology solutions, from Chicago and beyond September 23rd, 2022

“Twisty” photons could turbocharge next-gen quantum communication: Team’s on-chip technology uses orbital angular momentum to encode more information into a single photon September 23rd, 2022

Wrapping of nanosize copper cubes can help convert carbon dioxide into other chemicals September 23rd, 2022

Nanobiotechnology

Georgia State researchers discover novel way to treat IBD with lipid nanoparticles August 26th, 2022

Rice team eyes cells for sophisticated data storage: National Science Foundation backs effort to turn living cells into equivalent of computer RAM August 19th, 2022

Engineers fabricate a chip-free, wireless electronic “skin”: The device senses and wirelessly transmits signals related to pulse, sweat, and ultraviolet exposure, without bulky chips or batteries August 19th, 2022

Immune system: First image of antigen-bound T-cell receptor at atomic resolution: Antigen binding does not trigger any structural changes in T-cell receptors – Signal transduction probably occurs after receptor enrichment August 19th, 2022

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More











ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project